AtriCure sees losses narrow in Q3

AtriCure, a provider of cardiac surgical ablation systems, has reported its 2008 third quarter fiscal results, which ended Sept. 30.

The net loss for the third quarter of 2008 was $1.8 million as compared to $2.6 million for the third quarter of 2007, an improvement of 31.9 percent, according to the West Chester, Ohio-based company.   
Yet, AtriCure booked overall revenues of $14.8 million, a 22.8 percent increase over the third quarter of 2007, and a slight sequential decrease of 0.4 percent, or $100,000 compared to the second quarter of 2008.

Broken down by segments, the company reported revenues from domestic open-heart products were $6.7 million, consistent with third quarter 2007 revenues and a 10.1 percent sequential decrease. Revenues from domestic minimally invasive products were a record $5.7 million, representing a 62.5 percent increase over third quarter 2007 revenues of $3.5 million and a sequential increase of 11.7 percent. International revenues were a record $2.4 million for the third quarter of 2008, a 29 percent increase over third quarter 2007 revenues of $1.8 million and a sequential increase of 4.2 percent.
During the third quarter, the company said its net cash increased from $900,000 to $12.2 million. On July 1, the company entered into a $10 million, two-year revolving credit facility.

Around the web

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.